27th April 2023
10th January 2023
NextPoint Therapeutics Announces $80 Million Series B Financing to Advance Novel Immuno-Oncology Programs
9th September 2022
Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Molecules to Modulate and Repair Disease-Driving Proteins
31st August 2022
Umoja’s Unified Approach to Exceeding the Limitations of Cell Therapy
25th August 2022
Aktis Oncology Raises $84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals
18th August 2022
Orna Goes Into Orbit on $3.65B Merck Megadeal, $221M Series B Round
16th August 2022
Orna Therapeutics: Circular Logic
16th August 2022
Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
16th August 2022
Orna Therapeutics Raises $221 Million Series B Financing to Advance Circular RNA Platform, Accelerate Programs to the Clinic
2nd June 2022